NCT04972097 2025-02-12
PRESERVE
Angiodynamics, Inc.
Phase NA Completed
Clinical Trials
18 trialsNCT02791503 2022-12-20
CROSSFIRE
Amsterdam UMC, location VUmc
Phase NA Completed
NCT03257150 2022-08-11
A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer
University Health Network, Toronto
Phase NA Completed
NCT02333773 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02335112 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02335827 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02425059 2021-09-05
Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430610 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430623 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430636 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430662 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430688 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430701 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430766 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430779 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02981719 2021-01-22
Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02828865 2020-07-07
A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers
National Taiwan University Hospital
Phase NA Completed
NCT02010801 2013-12-13
Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors
National Taiwan University Hospital
Phase NA Completed